Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.75 | €19.86 | 245.477% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Cocrystal Pharma Inc. | 6 | 0 | 1 | 0 | €1.38 | €10.08 | 630.290% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.52 | €38.19 | 95.714% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.85 | €99.50 | 8.329% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €86.92 | - | - |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.66 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €342.00 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €42.40 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.32 | €5.00 | 15.741% |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €12.95 | €13.50 | 4.247% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €6.87 | €10.00 | 45.645% |
| Icon plc | 18 | 0 | 6 | 0 | €288.20 | €318.99 | 10.685% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.35 | €294.28 | 16.617% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.46 | €4.00 | 62.602% |
| Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €13.30 | €21.53 | 61.874% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €84.80 | €100.00 | 17.925% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Geron Corp. | 10 | 0 | 2 | 0 | €3.54 | €4.59 | 29.867% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €23.80 | €26.58 | 11.687% |
| Corcept Therapeutics Inc. | 9 | 0 | 2 | 0 | €21.32 | €33.55 | 57.348% |